Edward Morrow Atkinson III, EVP, Chief Technical Operations Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,370 shares at $459.83 ($2.0M) on 2025-02-11, disclosed to the SEC on 2025-02-12.
Scheduled sale ($2.0M) by EVP, Chief Technical Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $467.98 | 876 | $410K | 20.3% |
| 2 | $459.83 | 1,747 | $803K | 39.8% |
| 3 | $459.83 | 1,747 | $803K | 39.8% |
| Total | $461.46 avg | 4,370 | $2.0M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-12 | $806K | — | Filing → |
| VRTX | SELL | 2025-11-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $1.3M | — | Filing → |